TuHURA Biosciences announces acceptance of Phase 1b clinical trial results for poster presentation at the 2024 American Society of Clinical Oncology Annual Meeting; Kintara Therapeutics and TuHURA propose a merger.
AI Assistant
TUHURA BIOSCIENCES INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.